Induction of phase 2 detoxification enzymes by phenolic antioxidants can account for prevention of tumor initiation but cannot explain why these compounds inhibit tumor promotion. Phase 2 genes are induced through an antioxidant response element (ARE). Although the ARE resembles an AP-1 binding site, we show that the major ARE binding and activating protein is not AP-1. Interestingly, 
nolic antioxidants.
Phenolic antioxidants exhibit anti-inflammatory, antiatherosclerotic, and anticarcinogenic activities (1) . Although the mechanism of anticarcinogenesis is not well understood, it may include induction of the phase 2 detoxification enzymes glutathione S-transferases and quinone reductase (2) . Protection may also be provided by inhibition of phase 1 enzymes, which activate precarcinogens (3) . While these mechanisms can explain how phenolic antioxidants prevent tumor initiation, they do not explain why they interfere with tumor promotion (4, 5) . The mechanisms accounting for the latter activity are largely unknown. Paradoxically, at high doses phenolic antioxidants are tumor promoters (1) .
Induction of the glutathione S-transferase Ya subunit and quinone reductase genes is mediated through an antioxidant (or electrophile) response element (ARE, or EpRE) (6) (7) (8) (9) (10) (11) . The similarity between the ARE and the 12-0-tetradecanoylphorbol 13-acetate (TPA) response element (TRE) recognized by AP-1, a transcription factor that mediates gene induction by phorbol esters and other tumor promoters (12) , suggested that AP-1 also activates phase 2 genes. Indeed, induction of AP-1 binding activity by phenolic antioxidants was reported (13, 14) , and it was suggested to bind to the ARE (10, 13, 14) .
AP-1 is a dimeric DNA binding protein composed of the products of the jun and fos protooncogenes (12) . The Jun
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proteins (c-Jun, JunB, and JunD) form homo-and heterodimers, whereas the Fos proteins (c-Fos, FosB, Fra-1, and Fra-2) cannot associate with each other but form very stable heterodimers with any of the Jun proteins (12, (15) (16) (17) . Despite their high degree of sequence conservation, the Jun and Fos proteins exhibit different abilities to activate target genes (18) (19) (20) (21) (22) (23) . While c-Fos-containing heterodimers activate AP-1 target genes (17, 19) , Fra-containing heterodimers do not (23) . The biological functions of individual AP-1 complexes are largely unknown.
We investigated the relationship between AP-1 and the transcription factor that activates phase 2 genes by binding to the ARE. Although AP-1 binds with low affinity to the ARE, the major ARE binding and activating protein is not related to AP-1. In the course of these studies, we found that phenolic antioxidants such as tert-butylhydroquinone (BHQ) prevented induction of AP-1 transcriptional activity by TPA. This inhibition involves a change in composition of the AP-1 complex. Treatment with BHQ caused the appearance of AP-1 complexes containing high levels of Fra rather than Fos proteins. In cotransfection experiments, Fra-1 repressed activation of a reporter gene by Fos-containing AP-1 complexes. As a variety of different tumor promoters, including phorbol esters, UV irradiation, and the trace metal ion As3+, stimulate AP-1 transcriptional activity (refs. 12, 24, and 25; M.C., K.Y., and M.K., unpublished results), these findings suggest a mechanism that can explain the anti-tumor-promoting activity of phenolic antioxidants.
MATERIALS AND METHODS
HeLa, HepG2, and F9 cells were grown and transfected as described (18-20, 24, 26) . After transfection, cells were incubated in medium containing 0.1% fetal bovine serum for 20-24 h and were exposed to the various compounds when confluent. Extracts were prepared 18-24 h later, and chloramphenicol acetyltransferase (CAT) and luciferase (LUC) activities were measured. Most of the different reporters and expression vectors have been described (18-20, 27, 28) . The ARE-LUC reporter was derived from the 2XTRE-LUC reporter (29) by replacing the TREs with the synthetic ARE shown below. The Fra-1 expression vector was constructed by inserting the rat fra-1 cDNA (30) into the pSRa expression vector.
Cells were serum starved for 24 h and then exposed to BHQ or TPA. Nuclear extracts were prepared as described (29) . Binding reactions were carried out as described (20) The DNA-protein complexes were resolved on a 5% nondenaturating polyacrylamide gel at room temperature. To examine the presence of Fra-1 and c-Jun in the AP-1 complexes, anti-Fra-1 (a gift from R. Bravo, Bristol-Meyers Squibb, Princeton) or anti-c-Jun (G56-206.6, Pharmingen) antibodies were added to the reaction mixture.
Total cytoplasmic RNAs were prepared and analyzed as described (25) . Nuclear extracts were separated on an SDS/ 10% polyacrylamide gel, transferred to an Immobilon-P membrane (Millipore), and subjected to immunoblot analysis (31) using anti-Fra-1 antiserum generated against a synthetic peptide corresponding to amino acids of 2-14 of human Fra-1.
RESULTS
The Major ARE Binding Protein Is Not AP-1. We examined whether AP-1 binds to the ARE. Nuclear extracts were prepared from HepG2 cells treated with BHQ or TPA. A synthetic 51-bp fragment containing the ARE of the mouse glutathione S-transferase Ya gene (13) and a 30-bp fragment containing the collagenase TRE (26) were used as probes. BHQ did not increase the ARE-specific binding activity (Fig.  1A) . Similar results were obtained with longer exposure to BHQ (up to 24 h) or TPA (data not shown). TPA, however, induced AP-1 DNA binding activity and the appearance of a weak ARE binding activity that comigrated with AP-1 (Fig.  1B) . The mobilities of the AP-1-TRE and AP-1-ARE complexes were different from the major protein-ARE complex. Unlabeled ARE did not compete for AP-1 binding, and unlabeled TRE did not interfere with formation of the major protein-ARE complex, although it competed for binding of AP-1 to the ARE (Fig. 1B) . Similar results were obtained with BHQ-and TPA-treated HeLa cells (data not shown). Thus, AP-1 binds to the ARE with very low affinity, and, as suggested by Nguyen and Picket (32) , the major ARE binding protein is not AP-1. However, it is still possible that despite weak binding to the ARE, overexpression of AP-1 proteins may lead to modest activation of ARE-containing promoters as reported (13, 14) . Interestingly, exposure to BHQ stimulated AP-1 DNA binding activity in both HeLa and HepG2 cells (data not shown).
BHQ Suppresses Induction of AP-1 Transcriptional Activity. To determine whether AP-1 participates in induction of phase 2 genes by phenolic antioxidants, we examined the effect of BHQ on AP-1 transcriptional activity in HeLa cells. We found that the induction of two AP-1-dependent reporters by TPA was repressed in a dose-dependent manner by BHQ ( Fig.  2A and data not shown). BHQ alone did not affect either reporter (data not shown). Similar suppression of reporter gene induction was also observed in HepG2 cells (data not shown). Neither compound affected the Rous sarcoma virus (RSV)-CAT reporter, which lacks a functional TRE (Fig. 2A) or a f-actin-CAT reporter (data not shown). Therefore, the suppressive effect of BHQ is specific for AP-1-dependent promoters activated by TPA and is not due to general inhibition of translation or transcription.
By contrast, BHQ stimulated expression of a LUC reporter driven by a truncated prolactin promoter upstream to which an ARE was placed, upon transfection into HepG2 (Fig. 2B) 24 hr, then exposed to BHQ (60 ,uM) (A) or TPA (100 ng/ml) (B). At the indicated time points (in h), the cells were harvested and nuclear extracts were prepared. Five-microgram samples were incubated with 32P-labeled ARE (A, lanes 1-5; B, lanes 7-9) or TRE (B, lanes 1-6) probe. To determine the specificity of binding, the 6-h extracts were incubated with the probes in the presence of a 100-fold molar excess of unlabeled ARE or TRE competitor (comp.). The bound and free probes were separated by gel electrophoresis and visualized by autoradiography. The positions of the specific protein-DNA complexes are indicated by the arrows. BHQ. A similar reporter containing two TREs (2XTRE-LUC), however, was induced only by TPA. Most importantly, the ARE-LUC reporter was inducible by BHQ in F9 teratocarcinoma cells (Fig. 2C ). These cells do not express endogenous AP-1 activity (19) , and congruently the 2XTRE-LUC reporter was not inducible by TPA or BHQ. Thus the major ARE binding activity is not AP-1, its response to BHQ is very different from that of AP-1, and its activation can occur in the absence of AP-1. However, it is still possible that the synergistic activation of the ARE reporter by BHQ plus TPA 3 . Effects of BHQ onjun andfos gene expression. HeLa cells were serum starved for 24 h and treated with BHQ (60 ,uM) for the indicated times (in h). Total cytoplasmic RNAs were prepared, and 10-,ug samples were subjected to Northern analysis using probes specific for c-jun, junB, junD, c-fos, fra-1, and fra-2. treatment, no significant effect was observed, but after 3 h c-jun, junB, fra-1, and fra-2 expression was markedly induced (Fig. 3) . On the other hand, c-fos was very weakly induced, junD expression was essentially constitutive, and fosB transcripts were undetectable. BHQ treatment does not interfere with the signaling pathway activated by TPA, because induction of c-fos by TPA was not affected by a 6-h BHQ pretreatment (data not shown). rI (data not shown). Nuclear extracts were also incubated with anti-c-Jun and anti-Fra-1 antibodies and analyzed by a mobility shift assay (Fig. 4) Fra-1 Inhibits AP-1 Transcriptional Activity. Unlike c-Fos, Fra-1 and Fra-2 proteins lack a transcriptional activation function (23) . Therefore, the preferential induction of Fracontaining AP-1 complexes may explain the inhibitory effect of BHQ. To examine this possibility, we cotransfected the -73Col-CAT reporter with increasing amounts of a Fra-1 expression vector. This resulted in a dose-dependent inhibition of collagenase promoter activation by TPA (Fig. 5A) . As shown in Fig. SB, Fra-1 also repressed AP-1 activity generated by cotransfection of c-Jun and c-Fos expression vectors into F9 cells. Similar results were obtained using the ARE-LUC reporter, which is modestly activated by c-Jun and c-Fos (data not shown). We also examined the transcriptional activity of c-Fos-Fra-1 chimeras. While a chimeric protein containing the N-terminal half of c-Fos and the C-terminal half of Fra-1 had the same low activity as Fra-1, the converse chimera containing the N-terminal half of Fra-1 and the C-terminal half of c-Fos was almost as active as c-Fos (data not shown). A c-Fos deletion mutant lacking the C-terminal activation domain (33) had the same low activity as Fra-1.
Onl Redox-Active Phenolic Antioxidants Inducefra-1. We also examined the effects of the BHQ analogs 1,2-diphenol (catechol), 1,3-diphenol (resorcinol), and 1,4-diphenol (hydroquinone) on fra-1 and c-jun expression. Only the redox-active BHQ analogs catechol and hydroquinone induced c-jun and fra-1 expression (Fig. 6) . No effect was observed with redoxinactive resorcinol. These results reveal that the ability to undergo redox cycling (34) is required for induction of fra-1 and c-jun by phenolic antioxidants. The butyl group of BHQ appears to augment its activity in comparison to the nonbutylated analog hydroquinone. Redox cycling of these diphenols results in conversion into the corresponding quinones, which are likely to be the active principles in the induction process, due to their electrophilic nature (11) .
DISCUSSION
As shown above, the ARE-binding protein(s) that mediates induction of phase 2 genes by phenolic antioxidants is not AP-1. Most critically, the ARE confers an effective response to BHQ even in cells lacking AP-1 activity. In addition, AP-1 transcriptional activity is inhibited by BHQ. Our results are therefore consistent with those of Nguyen et al. (34) . Others, however, suggested that AP-1 may be the activator of the ARE (10, 13, 14) . We also find that an AP-1-like entity binds weakly The most important and unexpected finding of the present study is that despite its ability to induce AP-1 binding activity, BHQ suppresses TPA-induced AP-1 transcriptional activity. Although certain phenolic antioxidants inhibit protein kinase C activity (36) , this cannot account for their effect on AP-1 activity. At the doses used here, BHQ did not inhibit the activation of protein kinase ERK2 or the induction of c-fos expression by TPA (K.Y., unpublished results). The inhibition of AP-1 activity by BHQ appears to involve a change in the composition of the AP-1 complex. Unlike TPA, which effectively induces c-jun and c-fos but is a delayed and weak inducer offra-1 andfra-2 (18, 37) , BHQ effectively induces c-jun, junB, fra-1, and fra-2, but not c-fos. Thus, TPA-induced AP-1 complexes contain mostly c-Fos, whereas BHQ-induced AP-1 complexes contain mostly Fra-1 and probably also Fra-2. Although capable of heterodimerization with Jun proteins and binding to AP-1 sites, the Fra proteins are devoid of transcriptional activation function (23) . In c-Fos this function resides in its C-terminal region (32) , which is absent from Fra-1 and -2. Therefore, the difference between the composition of BHQinduced AP-1 complexes and those induced by phorbol esters or other mitogens can explain how BHQ suppresses AP-1 activity. Indeed, we find that transient expression of Fra-1 suppresses AP-1 activity. Similar inhibitory effects on AP-1 activity of a truncated form of FosB, as well as Fra-1 and Fra-2, were reported (23, 38) .
An intriguing question is how phenolic antioxidants induce fia-1 andfra-2 expression. Their failure to induce high level of c-fos orfosB expression indicates that their activity is specific and distinct from that of other inducers, such as TPA, UV, and H202, which induce c-fos to a much higher extent than any of thefra genes (25) . Only redox-active compounds, which can be converted intracellularly to electrophilic quinones, induce fra-1. Among these compounds, BHQ is the most potent inducer. Similar activity profiles were found when the abilities of these compounds to induce quinone reductase expression (33) or an ARE-dependent reporter gene (11) were measured.
Since the electron-donating butyl group stabilizes the quinone form, BHQ has a lower reduction potential than hydroquinone (39) . Alternatively, the butyl group makes BHQ more lipophilic and thus facilitates its cellular uptake. The induction of fra-1 and fra-2, as well as c-jun, by BHQ is relatively slow. This is consistent with formation of the quinone form, which is the actual mediator of the response, through redox cycling.
It is unlikely that phenolic antioxidants simply cause oxidative stress, as their effect on the pattern of jun and fos gene expression' is very different from that of H202 (25) . These findings also suggest that thefra-1 gene may contain an ARE.
Indeed, an examination of the 5'-flanking region of the human fra-1 gene (40) reveals such a potential sequence at positions -104 through -94. The ability of phenolic antioxidants to inhibit AP-1 activity through preferential induction of Fra-containing AP-1 complexes stands in'marked contrast to the ability of diverse tumor promoters, including phorbol esters (26) , UV irradiation (24, 25) , and As3+ (M.C., K.Y., and M.K., unpublished results), to induce AP-1 activity. As expression of dominant-negative jun mutants reverts the transformed phenotype (41) , it is also possible that' highly effective and specific inducers of fra expression may be useful both in chemoprevention and in cancer therapy.
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